Literature DB >> 6540453

The effect of apomorphine on the open-field behavior of rats: alone and in pairs.

H L Chow, H M Beck.   

Abstract

Male rats were observed in the open-field while alone and while in pairs in an alternating series of trials. The trials extended over a 78 min session following injections of either saline (0.9%) or apomorphine (5.0 mg/kg, IP) into the observed member of each pair. Contrary to the literature on apomorphine stereotypy, apomorphine did not induce continuous sniffing of the environment and continuous gnawing in most rats. Sniffing of the environment remained at normal levels but there was an increase in nodding the head in the vertical plane while keeping the snout close to the floor. Apomorphine-induced hyperactivity was attributed to two factors: a sustained increase in the duration of bouts of locomotion and a failure of the frequency of bouts of locomotion to habituate to novelty. Apomorphine eliminated all social behavior directed toward the other rat, however apomorphine rats showed they were sensible to the presence of the other by increasing their locomotion and rearing when the partner was introduced.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6540453     DOI: 10.1016/0091-3057(84)90135-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice.

Authors:  Ivan O Medvedev; Amy J Ramsey; Shababa T Masoud; Marie Kristel Bermejo; Nikhil Urs; Tatyana D Sotnikova; Jean-Martin Beaulieu; Raul R Gainetdinov; Ali Salahpour
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

2.  Pharmacological analysis of zebrafish lphn3.1 morphant larvae suggests that saturated dopaminergic signaling could underlie the ADHD-like locomotor hyperactivity.

Authors:  Merlin Lange; Cynthia Froc; Hannah Grunwald; William H J Norton; Laure Bally-Cuif
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-02-26       Impact factor: 5.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.